EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering

Bing-Juan Li iD, Jiao-Jiao Zhuo iD, Meng-Ran Tian, Dan Meng, Hong-Yan Li iD

Molecules · 2026

DOI: 10.3390/molecules31040711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Bing-Juan Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Food and Biotechnology, Department of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China. Hauptthemen laut MEDLINE: Equol, Isoflavones, Protein Engineering, Oxidoreductases. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As an isoflavone metabolite with diverse physiological activities, the development of efficient and sustainable manufacturing technologies for (S)-equol holds significant importance. This study focuses on the semi-rational design of daidzein reductase (DZNR), the first key enzyme in the (S)-equol biotransformation pathway. Through multiple sequence alignment and three-dimensional structural analysis, two critical residues, Gly30 and Ala105, were identified in DZNR. A library of single and combinatorial mutants was constructed and screened, yielding the double variant DZNR30S+105S with substantially enhanced catalytic performance. In a whole-cell biocatalytic system, the recombinant E. coli (Escherichia coli) strain harboring this combinatorial mutant achieved a yield of 238.3 mg/L (S)-equol at a substrate concentration of 1 mM daidzein, demonstrating markedly improved catalytic efficiency. Upon increasing the daidzein concentration to 2 mM, the reaction reached equilibrium within 5 h, producing 384.6 mg/L (S)-equol, which highlights the mutant’s excellent potential for high-substrate-concentration applications. This study not only provides novel mechanistic insights into DZNR catalysis but also successfully establishes a DZNR variant with enhanced activity, offering an efficient biocatalytic component for the industrial-scale biomanufacturing of (S)-equol and thereby advancing the development of green biosynthesis technologies for this valuable compound.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EquolIsoflavonesProtein EngineeringOxidoreductasesEscherichia coliBiocatalysisModels, MolecularMutationSubstrate SpecificityMutagenesis, Site-Directed

Stichwörter der Autor:innen

(S)-equoldaidzein reductaseenzyme engineeringsemi-rational designsite-directed mutagenesissoy isoflavones

Substanzen

EquolIsoflavonesdaidzeinOxidoreductases

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Food and Biotechnology, Department of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China.

ORCID-Profile: Bing-Juan Li, Jiao-Jiao Zhuo, Hong-Yan Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, B. J., Zhuo, J. J., Tian, M. R., Meng, D., & Li, H. Y. (2026). A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering. Molecules. https://doi.org/10.3390/molecules31040711

Vancouver

Li BJ, Zhuo JJ, Tian MR, Meng D, Li HY. A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering. Molecules. 2026. doi:10.3390/molecules31040711

BibTeX
@article{Li2026,
  author = {Li, Bing-Juan and Zhuo, Jiao-Jiao and Tian, Meng-Ran and Meng, Dan and Li, Hong-Yan},
  title = {A Whole-Cell Catalytic System for Equol Production Based on Daidzein Reductase Engineering},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31040711}
}
Kostenlos starten →